Clinical staging and prognostic markers in chronic lymphocytic leukemia.
In this article we provide a brief review of the two staging systems in chronic lymphocytic leukemia, and we discuss the more recently identified, new prognostic markers that are of interest to clinicians and researchers in this field.
Rai
Kanti R
KR
Long Island Jewish Medical Center, Division of Hematology-Oncology, 270-05 76th Avenue, New Hyde Park, NY 11040, USA. rai@lij.edu
Wasil
Tarun
T
Iqbal
Uzma
U
Driscoll
Nancy
N
Patel
Dilip
D
Janson
Dale
D
Mehrotra
Bhoomi
B
D014408:Biomarkers, Tumor / Q000032:analysis; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000473:pathology* / Q000628:therapy; D008099:Liver / Q000473:pathology; D018655:Lymphocyte Count; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D013154:Spleen / Q000473:pathology
D014408:Biomarkers, Tumor